Your browser doesn't support javascript.
loading
Mostrar: 20 | 50 | 100
Resultados 1 - 3 de 3
Filtrar
Más filtros

Bases de datos
Tipo del documento
Asunto de la revista
País de afiliación
Intervalo de año de publicación
1.
Proc Biol Sci ; 286(1904): 20190401, 2019 06 12.
Artículo en Inglés | MEDLINE | ID: mdl-31185860

RESUMEN

The diversity of teeth patterns in actinopterygians is impressive with tooth rows in many locations in the oral and pharyngeal regions. The first-formed tooth has been hypothesized to serve as an initiator controlling the formation of the subsequent teeth. In zebrafish, the existence of the first tooth (named 4 V1) is puzzling as its replacement is induced before the opening of the mouth. Functionally, it has been shown that 4 V1 formation requires fibroblast growth factor (FGF) and retinoic acid (RA) signalling. Here, we show that the ablation of 4 V1 prevents the development of the dental row demonstrating its dependency over it. If endogenous levels of FGF and RA are restored after 4 V1 ablation, embryonic dentition starts again by de novo formation of a first tooth, followed by the dental row. Similarly, induction of anterior ectopic teeth induces subsequent tooth formation, demonstrating that the initiator tooth is necessary and sufficient for dental row formation, probably via FGF ligands released by 4 V1 to induce the formation of subsequent teeth. Our results show that by modifying the formation of the initiator tooth it is possible to control the formation of a dental row. This could help to explain the diversity of tooth patterns observed in actinopterygians and more broadly, how diverse traits evolved through molecular fine-tuning.


Asunto(s)
Dentición , Pez Cebra/crecimiento & desarrollo , Animales , Tipificación del Cuerpo , Factores de Crecimiento de Fibroblastos/metabolismo , Factores de Crecimiento de Fibroblastos/farmacología , Factores de Crecimiento de Fibroblastos/fisiología , Transducción de Señal , Diente/anatomía & histología , Diente/efectos de los fármacos , Diente/crecimiento & desarrollo , Tretinoina/metabolismo , Tretinoina/farmacología , Tretinoina/fisiología , Pez Cebra/anatomía & histología , Pez Cebra/embriología
2.
Mol Cell Endocrinol ; 529: 111267, 2021 06 01.
Artículo en Inglés | MEDLINE | ID: mdl-33839219

RESUMEN

Osteoporosis is an increasing burden on public health as the world-wide population ages and effective therapeutics are severely needed. Two pathways with high potential for osteoporosis treatment are the retinoic acid (RA) and endocannabinoid system (ECS) signaling pathways. We sought to elucidate the roles that these pathways play in bone development and maturation. Here, we use chemical treatments to modulate the RA and ECS pathways at distinct early, intermediate, and late times bone development in zebrafish. We further assessed osteoclast activity later in zebrafish and medaka. Finally, by combining sub-optimal doses of AR and ECS modulators, we show that enhancing RA signaling or reducing the ECS promote bone formation and decrease osteoclast abundance and activity. These data demonstrate that RA signaling and the ECS can be combined as sub-optimal doses to influence bone growth and may be key targets for potential therapeutics.


Asunto(s)
Endocannabinoides/metabolismo , Oryzias/genética , Transducción de Señal/genética , Factores de Transcripción/genética , Tretinoina/metabolismo , Proteínas de Pez Cebra/genética , Pez Cebra/genética , Animales , Desarrollo Óseo/efectos de los fármacos , Desarrollo Óseo/genética , Embrión no Mamífero , Regulación del Desarrollo de la Expresión Génica , Oryzias/crecimiento & desarrollo , Oryzias/metabolismo , Osteoclastos/citología , Osteoclastos/efectos de los fármacos , Osteoclastos/metabolismo , Osteogénesis/efectos de los fármacos , Osteogénesis/genética , Osteonectina/genética , Osteonectina/metabolismo , Rimonabant/farmacología , Factor de Transcripción Sp7/genética , Factor de Transcripción Sp7/metabolismo , Factores de Transcripción/metabolismo , Tretinoina/farmacología , Pez Cebra/crecimiento & desarrollo , Pez Cebra/metabolismo , Proteínas de Pez Cebra/metabolismo
3.
Endocrinology ; 156(10): 3596-609, 2015 Oct.
Artículo en Inglés | MEDLINE | ID: mdl-26181105

RESUMEN

The endocannabinoid system (ECS) and retinoic acid (RA) signaling have been associated with influencing lipid metabolism. We hypothesized that modulation of these pathways could modify lipid abundance in developing vertebrates and that these pathways could have a combinatorial effect on lipid levels. Zebrafish embryos were exposed to chemical treatments altering the activity of the ECS and RA pathway. Embryos were stained with the neutral lipid dye Oil-Red-O (ORO) and underwent whole-mount in situ hybridization (WISH). Mouse 3T3-L1 fibroblasts were differentiated under exposure to RA-modulating chemicals and subsequently stained with ORO and analyzed for gene expression by qRT-PCR. ECS activation and RA exposure increased lipid abundance and the expression of lipoprotein lipase. In addition, RA treatment increased expression of CCAAT/enhancer-binding protein alpha. Both ECS receptors and RA receptor subtypes were separately involved in modulating lipid abundance. Finally, increased ECS or RA activity ameliorated the reduced lipid abundance caused by peroxisome proliferator-activated receptor gamma (PPARγ) inhibition. Therefore, the ECS and RA pathway influence lipid abundance in zebrafish embryos and have an additive effect when treated simultaneously. Furthermore, we demonstrated that these pathways act downstream or independently of PPARγ to influence lipid levels. Our study shows for the first time that the RA and ECS pathways have additive function in lipid abundance during vertebrate development.


Asunto(s)
Embrión no Mamífero/metabolismo , Endocannabinoides/metabolismo , Lípidos/análisis , Transducción de Señal , Tretinoina/metabolismo , Pez Cebra/metabolismo , Células 3T3-L1 , Adipogénesis/efectos de los fármacos , Animales , Compuestos Azo/química , Embrión no Mamífero/efectos de los fármacos , Embrión no Mamífero/embriología , Endocannabinoides/farmacología , Regulación del Desarrollo de la Expresión Génica , Hibridación in Situ , Metabolismo de los Lípidos/genética , Ratones , PPAR gamma/genética , PPAR gamma/metabolismo , Receptor Cannabinoide CB1/genética , Receptor Cannabinoide CB1/metabolismo , Receptor Cannabinoide CB2/genética , Receptor Cannabinoide CB2/metabolismo , Receptores de Ácido Retinoico/genética , Receptores de Ácido Retinoico/metabolismo , Receptor alfa de Ácido Retinoico , Reacción en Cadena de la Polimerasa de Transcriptasa Inversa , Coloración y Etiquetado/métodos , Tretinoina/farmacología , Pez Cebra/embriología , Pez Cebra/genética , Proteínas de Pez Cebra/genética , Proteínas de Pez Cebra/metabolismo
SELECCIÓN DE REFERENCIAS
DETALLE DE LA BÚSQUEDA